Home » Topics » BioWorld Science

BioWorld Science
RSS

Taisho discloses agents for urinary incontinence

Aug. 30, 1996

Reliance approved for marketing in U.S.

Aug. 30, 1996

Potential BPH therapeutics from Poli Industria Chimica

Aug. 30, 1996

U.S. agreement announced for ProstaFlo

Aug. 30, 1996

Terazosin and finasteride go head-to-head in BPH patients

Aug. 30, 1996

Antiplatelet agents described by Kissei

Aug. 30, 1996

TxA2/PGH2 antagonists described by Terumo

Aug. 30, 1996

Fibrinogen antagonists claimed by Thomae

Aug. 30, 1996

Fibrinogen antagonists from Nippon Steel

Aug. 30, 1996

Glaxo Wellcome claims fibrinogen antagonists

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...